Great Investment For Doctors: Joint Venture Pharmacies

by Pepper Hamilton LLP
Contact

This article originally was published in the Business & Law, Featured, and Finance sections of the Physicians News Digest Web site, www.physiciansnews.com, on December 12, 2013. Republished with permission.

With reimbursement levels declining, health care organizations, including pharmacies and physicians, continue to look for ways to diversify their businesses. A very attractive vehicle for increasing revenues has been ancillary joint venture arrangements, including joint venture pharmacies.

Joint ventures among physicians and health care companies were once commonplace in the health care industry. With stricter enforcement of the federal Anti-Kickback Statute and the passage of Stark, however, the industry quickly saw a decline in these ventures, many being acquired, merged out of existence and even sold. Greater certainty of state laws and the finalization of federal laws, however, has helped guide legitimate joint ventures.

Corporate Practice of Medicine/Pharmacy

The corporate practice of medicine doctrine, which has been adopted by certain states either through corporate formation statutes or case law, generally prohibits (with some exceptions) non-physicians from owning an interest in a medical practice (and the employment of physicians by non-physicians). This doctrine has been adopted by other licensed professions. Many states (although not all), however, permit non-pharmacists to own an interest in a pharmacy, thus allowing for non-licensed individuals or corporations to partner with pharmacies.

Federal Anti-Kickback Statute

Generally, the federal Anti-Kickback Statute prohibits an individual or entity from knowingly and willfully offering or paying, or from soliciting or receiving, remuneration in order to induce the referral or the arranging for the referral of business reimbursed by federal health care programs. The primary concern for a physician-pharmacy joint venture under the Anti-Kickback Statute (assuming it accepts federal health care program reimbursement) is whether distributions to investors constitute disguised remuneration for referrals. The U.S. Department of Health and Human Services Office of Inspector General (OIG) has adopted safe harbors to protect certain venture arrangements.

Safe Harbors

Historically, the investment interests safe harbor for small investments has been utilized to protect physician-hospital joint ventures. To get protection under this safe harbor, however, a physician-pharmacy joint venture has to satisfy a number of requirements, including what are commonly known as the 60/40 Investor Test and 60/40 Revenue Test. These tests require that no more than 40 percent of the value of the investment interests of each class of investment interests be held in the previous fiscal year or previous 12-month period (Look-Back Period) by investors who are in a position to generate business for the venture (Investment Test). In addition, no more than 40 percent of the venture’s gross revenue related to the furnishing of health care services in the Look-Back Period may come from business generated from investors (Revenue Test). Physician-pharmacy joint ventures may or may not be able to comply with these requirements. Typically, the difficulty will be with the Revenue Test. Complying with Stark, however, may be unlikely, forcing physician-pharmacy joint ventures to participate in non-federal health care programs only.

Stark

Generally, Stark prohibits a physician (or immediate family member) who has a financial relationship with an entity from making referrals to that entity for the furnishing of designated health services for which payment may be made under the federal health care programs, unless an exception or safe harbor is satisfied. Stark is often implicated in the physician joint venture context because physicians make referrals for designated health services, such as outpatient prescription drugs, to the entity and have an ownership or compensation relationship with the entity. Stark is a strict liability statute requiring compliance with an exception if the statute is implicated. Unfortunately, there is no exception that corresponds with the federal Anti-Kickback Statute’s small investment interests safe harbor that would protect the physician investment in the pharmacy.

State Laws

Many states have adopted anti-fraud and abuse and anti-referral laws and safe harbors and exceptions similar to the federal counterparts. Accordingly, even where physician-pharmacy joint ventures do not accept federal reimbursement, they will need to comply with applicable state laws. Additionally, medical practice acts and pharmacy board regulations may regulate referrals and over-utilization and, therefore, could also impact the structure of the venture. Finally, it is also good practice to structure any health care venture in accordance with OIG’s guidance in this area and the small investment interests safe harbor.

OIG’s Position on Joint Ventures

OIG has long been concerned with the fraud and abuse risk posed by health care ventures in which investors are also sources of referrals. In 1989, OIG issued a special fraud alert concerning suspect joint ventures. In the alert, OIG distinguishes between legitimate joint ventures and those that it considers suspect. Importantly, OIG indicated that under suspect joint ventures, physicians may be investors not so much for raising investment capital to start a business, but rather to lock up a stream of referrals from the physicians in exchange for compensation for those referrals. Some questionable features of suspect joint ventures include:

Selection and Retention of Investors

  • physician investors are chosen because they are in a position to make referrals to the venture
  • there is discrimination in the opportunity of physicians to invest based on their ability to make referrals
  • physician investors are encouraged to make referrals and may be encouraged to divest their ownership interest where they fail to maintain an acceptable level of referrals
  • the venture tracks referrals and distributes the information to investors.

Business Structure

  • one party to the joint venture may be an ongoing entity that is already engaged in a particular line of business and acts as the reference supplier under the arrangement with the venture, the venture being nothing more than a shell entity
  • the joint venture contracts out all of the services and conducts very few services on its own premises, even though it bills the federal health care programs for the services.

Financing and Profit Distributions

  • capital invested by physicians is disproportionately small, the risk involved in the venture is low, and the returns on investment are disproportionately large
  • physician investors may borrow their capital contribution from the entity and pay it back through deductions of profit distributions.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Pepper Hamilton LLP | Attorney Advertising

Written by:

Pepper Hamilton LLP
Contact
more
less

Pepper Hamilton LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.